Cell Growth & Differentiation, Vol 6, Issue 9 1071-1075, Copyright © 1995 by American Association of Cancer Research

ARTICLES

bcl-2 inhibits wild-type p53-triggered apoptosis but not G1 cell cycle arrest and transactivation of WAF1 and bax

Y Wang, I Okan, L Szekely, G Klein and KG Wiman
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.

We have earlier shown that wild-type (wt) p53 expressed from a temperature-sensitive construct (ts p53) triggers apoptosis in the v-myc retrovirus-induced, p53-negative T-cell lymphoma line J3D (Y. Wang et al., Cell Growth & Differ., 4: 467-473, 1993). We also found that constitutive bcl-2 expression inhibits wt p53-triggered apoptosis in these cells (Y. Wang et al., Oncogene, 8: 3427-3431, 1993). Here we demonstrate that more than 90% of the ts p53-transfected J3D cells were arrested in G1 at 18 h after induction of wt p53 expression by temperature shift to 32 degrees C. At this time, at least 80% of the cells remained viable. After 30 h at 32 degrees C, around 50% of the cells had died by apoptosis, while most of the remaining cells were still alive in G1, indicating that p53-induced apoptosis occurred following G1 arrest. The G1 cell cycle arrest at 18 h after temperature shift to 32 degrees C was reversible, as shown by the fact that the cells readily resumed exponential growth following temperature shift back to 37 degrees C, although viability dropped from around 80 to 65%. Expression of both WAF1 and bax mRNA was induced by wt p53 in both the ts p53 and ts p53/bcl-2 transfected cells. The kinetics of G1 cell cycle arrest at 32 degrees C was similar in both the ts p53 and the ts p53/bcl-2 double transfectants.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. Brown and S. Benchimol The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation: CELL CYCLE ARREST OR APOPTOSIS J. Biol. Chem., February 17, 2006; 281(7): 3832 - 3840. [Abstract] [Full Text] [PDF]

				K. Chylicki, M. Ehinger, H. Svedberg, and U. Gullberg Characterization of the Molecular Mechanisms for p53-mediated Differentiation Cell Growth Differ., November 1, 2000; 11(11): 561 - 571. [Abstract] [Full Text]

				W. Qian and K. G. Wiman Polyoma Virus Middle T and Small t Antigens Cooperate to Antagonize p53-induced Cell Cycle Arrest and Apoptosis Cell Growth Differ., January 1, 2000; 11(1): 31 - 39. [Abstract] [Full Text]

				B. A. Froesch, C. Aime-Sempe, B. Leber, D. Andrews, and J. C. Reed Inhibition of p53 Transcriptional Activity by Bcl-2 Requires Its Membrane-anchoring Domain J. Biol. Chem., March 5, 1999; 274(10): 6469 - 6475. [Abstract] [Full Text] [PDF]

				L. Tentori, P. M. Lacal, E. Benincasa, D. Franco, I. Faraoni, E. Bonmassar, and G. Graziani Role of Wild-Type p53 on the Antineoplastic Activity of Temozolomide Alone or Combined with Inhibitors of Poly(ADP-Ribose) Polymerase J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 884 - 893. [Abstract] [Full Text]

				Y. Liu, S. A. Bohn, and J. L. Sherley Inosine-5'-Monophosphate Dehydrogenase Is a Rate-determining Factor for p53-dependent Growth Regulation Mol. Biol. Cell, January 1, 1998; 9(1): 15 - 28. [Abstract] [Full Text]